logo

Below are provided the most significant PRO Instruments Linguistic Validation projects that I have completed starting from 2015 onwards.

• FSIQ-RMS (Fatigue Symptoms and Impacts Questionnaire - Relapsing Multiple Sclerosis) English to Belarusian translation and linguistic validation for Belarus
  Volume: ca 1200 words
  Languages: English to Belarusian
  Fields: Multiply sclerosis, quality of life
  English to Belarusian translation of FSIQ-RMS questionnaire and linguistic validation for Belarus.

• Work Productivity and Activity Impairment Questionnaire: Multiple Sclerosis V2.0 (WPAI:MS) translation from English to Belarusian for Belarus
  Volume: ca 500 words
  Languages: English to Belarusian
  Fields: Multiply sclerosis, quality of life
  English to Belarusian translation of WPAI:MS questionnaire for Belarus.

• FSIQ-RMS (Fatigue Symptoms and Impacts Questionnaire - Relapsing Multiple Sclerosis) English to Russian translation adaptation and linguistic validation for Belarus
  Volume: ca 1200 words
  Languages: English to Russian
  Fields: Multiply sclerosis, quality of life
  Adaptation of existing English to Russian translation of FSIQ-RMS questionnaire and linguistic validation for Belarus.

• EQ-5D-3L PDA Labels translation from English to Belarusian for Belarus
  Volume: ca 200 words
  Languages: English to Belarusian
  Fields: Quality of life
  Translation of EQ-5D-3L PDA Labels from English to Belarusian for Belarus.
  http://www.euroqol.org/eq-5d-products/eq-5d-3l.html

• EORTC QLQ-BR23 questionnaire English to Russian translation adaptation and Linguistic Validation for Belarus
  Volume: ca 400 words
  Languages: English to Russian
  Fields: Oncology, breast cancer
  Adaptation of English to Russian translation of EORTC QLQ-BR23 questionnaire and Linguistic Validation (testing on 10 breast cancer patients) for Belarus.
  www.proqolid.org/instruments/eortc_quality_of_life_questionnaire_breast_cancer_module

• A telephone based suicidality scale “Columbia Suicide Severity Rating Scale (eC-SSRS IVR)”—translation from English to Belarusian and Linguistic Validation for Belarus
  Volume: 4000 words
  Languages: English to Belarusian
  Fields: Psychiatry—suicidality assessment
  Translation from English to Russian and Linguistic Validation of the translation of the telephone based suicidality scale Columbia Suicide Severity Rating Scale (eC-SSRS IVR) scale for Belarus.
  www.proqolid.org/instruments/medical_outcomes_study_sleep_scale_mos_sleep

• Medical Outcomes Study (MOS) Sleep-12 Standard and Acute Questionnaires Linguistic Adaptation and Linguistic Validation for Belarus
  Volume: 800 words
  Languages: English to Russian
  Fields: Sleep disorders
  Linguistic Adaptation and Linguistic Validation of the English to Russian translation of the Medical Outcomes Study (MOS) Sleep-12 Standard and Acute Questionnaires scale for Belarus.
  www.cssrs.columbia.edu/ecssrs.html

• A telephone based suicidality scale—Columbia Suicide Severity Rating Scale (eC-SSRS IVR)—Linguistic Adaptation and Linguistic Validation for Belarus
  Volume: 4000 words
  Languages: English to Russian
  Fields: Psychiatry—suicidality assessment
  Linguistic Adaptation and Linguistic Validation of the English to Russian translation of the telephone based suicidality scale Columbia Suicide Severity Rating Scale (eC-SSRS IVR) scale for Belarus.
  www.cssrs.columbia.edu/ecssrs.html

• ASA-HCRUv4, Back Pain NRS, and OPAQ-PF Questionnaires Translation
  Volume: 2300 words
  Languages: English to Russian
  Fields: Rheumatology
  Translation from English into Russian of ASA-HCRUv4, Back Pain NRS, and OPAQ-PF questionnaires.

• IBPQ_8-item, PaAAP-VAS, and PaABP_1wk Questionnaires Translation
  Volume: 250 words
  Languages: English to Russian
  Fields: Rheumatology
  Translation from English into Russian of IBPQ_8-item, PaAAP-VAS, and PaABP_1wk questionnaires.

• DQL Questionnaire Translation
  Volume: 250 words
  Languages: English to Russian
  Fields: Endocrinology (Diabetes)
  Translation from English into Russian of DQL questionnaire.

• OABq, PPBC, TS-VAS, PGIC and WPAI Questionnaires Translation and Linguistic Validation
  Volume: 1100 words
  Languages: English to Russian for Belarus
  Fields: Urology
  Translation from English into Russian and linguistic validation for Belarus of OABq, PPBC, TS-VAS, PGIC and WPAI Questionnaires, including cognitive debriefing of five respondents with overactive bladder disorder.
  www.proqolid.org

• EQ-5D-5L Questionnaire Translation and Linguistic Validation
  Volume: 300 words
  Languages: English to Russian for Belarus
  Fields: Healthcare
  Translation from English into Russian and linguistic validation for Belarus of EQ-5D-5L Questionnaire, including cognitive debriefing of five respondents with various medical conditions.
  www.euroqol.org

• LupusQoL Questionnaire Linguistic Validation
  Languages: English to Russian for Belarus
  Fields: Rheumatology
  Linguistic validation for Belarus of the Russian translation of LupusQoL Questionnaire, including cognitive debriefing of five respondents with systemic lupus erythematosus.
  www.corptransinc.com/Sites/LupusQoL

• And many more…

Below are provided the most significant and recent Medical & Pharmaceutical Interpretation projects that I have completed starting from 2015 onwards.

• On-line simultaneous interpretation for a webinar “Daily Care Experience With Non-VKA Oral Anticoagulants (NOACs) – From Bench to Bedside”
  Date: August 20, 2015
  Locations: Dresden (Germany), Astana (Kazakhstan), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Dr. Jan Beyer-Westendorf, Head of Division "Thrombosis Research" and Deputy Head of Division "Vascular Medicine", Dresden University Clinic "Carl Gustav Carus"
  Topic: Use of novel oral anticoagulants in daily care of patients with atrial fibrillation and deep vein thrombosis
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of atrial fibrillation and deep vein thrombosis.

• On-line simultaneous interpretation for a webinar “Daily Use of Novel Anticoagulants in AF:The EHRA Practical Guide”
  Date: July 08, 2015
  Locations: Leuven (Belgium), Tbilisi (Georgia), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Hein Heidbuchel, Hasselt University
  Topic: Daily use of novel oral anticoagulants for the treatment of atrial fibrillation
  Number of participants: 10
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of atrial fibrillation.

• On-line simultaneous interpretation for a webinar “Daily Care Experience With Non-VKA Oral Anticoagulants (NOACs) – From Bench to Bedside”
  Date: June 30, 2015
  Locations: Dresden (Germany), Kiev (Ukraine), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Dr. Jan Beyer-Westendorf, Head of Division "Thrombosis Research" and Deputy Head of Division "Vascular Medicine", Dresden University Clinic "Carl Gustav Carus"
  Topic: Use of novel oral anticoagulants in daily care of patients with atrial fibrillation and deep vein thrombosis
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of atrial fibrillation and deep vein thrombosis.

• On-line simultaneous interpretation for a webinar “Anticoagulation in atrial fibrillation: translating evidence in practice”
  Date: June 25, 2015
  Locations: Paris (France), Astana (Kazakhstan), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Professor J.Y. LE Heuzey, Georges Pompidou Hospital, René Descartes University, Paris
  Topic: Anticoagulation in atrial fibrillation
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of atrial fibrillation.

• On-line simultaneous interpretation for a webinar “Daily Care Experience With Non-VKA Oral Anticoagulants (NOACs) – From Bench to Bedside”
  Date: June 25, 2015
  Locations: Dresden (Germany), Astana (Kazakhstan), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Dr. Jan Beyer-Westendorf, Head of Division "Thrombosis Research" and Deputy Head of Division "Vascular Medicine", Dresden University Clinic "Carl Gustav Carus"
  Topic: Use of novel oral anticoagulants in daily care of patients with atrial fibrillation and deep vein thrombosis
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of atrial fibrillation and deep vein thrombosis.

• On-line simultaneous interpretation for a webinar “Controversies in the Management of Pulmonary Embolism”
  Date: June 17, 2015
  Locations: Leuven (Belgium), Moscow (Russa), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Peter Verhamme, Vascular Medicine and Haemostasis, Department of Cardiovascular Medicine, University of Leuven
  Topic: Use of novel oral anticoagulants in the treatment of pulmonary embolism and deep vein thrombosis
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of pulmonary embolism and deep vein thrombosis.

• On-line simultaneous interpretation for a webinar “Optimal Anticoagulation in Patients With Atrial Fibrillation Scheduled for Cardioversion ”
  Date: June 10, 2015
  Locations: Milan (Italy), Astana (Kazakhstan), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Riccardo Cappato, The University of Milan
  Topic: Optimal Anticoagulation in Patients With Atrial Fibrillation Scheduled for Cardioversion
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of VTE.

• On-line simultaneous interpretation for a webinar “VTE case drive responsible use of novel oral anticoagulants”
  Date: June 5, 2015
  Locations: Munich (Germany), Moscow (Russia), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Sylvia Haas, Institute for Experimental Oncology and Therapy Research, Technical University of Munich
  Topic: Responsible use of novel oral anticoagulants for the treatment of VTE
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of VTE.

• On-line simultaneous interpretation for a webinar “VTE case drive responsible use of novel oral anticoagulants”
  Date: May 28, 2015
  Locations: Munich (Germany), Moscow (Russia), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Sylvia Haas, Institute for Experimental Oncology and Therapy Research, Technical University of Munich
  Topic: Responsible use of novel oral anticoagulants for the treatment of VTE
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of VTE.

• On-line simultaneous interpretation for a webinar “Rationale of once-daily dosing of novel OACs”
  Date: May 22, 2015
  Locations: Berlin (Germany), Moscow (Russia), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Professor, Dr. Reinhold Kreutz, Charité – University Medicine Berlin, Germany
  Topic: Use of novel oral anticoagulants treatment and prevention of VTE, DVT and PE
  Number of participants: 30
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants treatment and prevention of VTE, DVT and PE.

• On-line simultaneous interpretation for a webinar “Choosing the right anticoagulant for the AF patient and switching to it appropriately”
  Date: May 14, 2015
  Locations: Leuven (Belgium), Moscow (Russia), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Hein Heidbuchel, University of Leuven
  Topic: Use of novel oral anticoagulants for the treatment of VTE
  Number of participants: 10
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of VTE.

• On-line simultaneous interpretation for a webinar “VTE case drive responsible use of novel oral anticoagulants”
  Date: May 11, 2015
  Locations: Munich (Germany), Kiev (Ukraine), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. Sylvia Haas, Institute for Experimental Oncology and Therapy Research, Technical University of Munich
  Topic: Responsible use of novel oral anticoagulants for the treatment of VTE
  Number of participants: 10
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to use of novel oral anticoagulants for the treatment of VTE.

• On-line simultaneous interpretation for a webinar “Primary Prevention of Stroke in Atrial Fibrillation”
  Date: May 08, 2014
  Locations: London (United Kingdom), Almaty (Kazakhstan), Grodno (Belarus)
  Duration: 1 hour
  Languages: English to Russian, Russian to English
  Field: Cardiology
  Lecturer: Prof. Dr. John Camm, St. George's University of London
  Topic: Primary Prevention of Stroke in Atrial Fibrillation
  Number of participants: 10
  Simultaneous interpretation from English to Russian and Russian to English for on-line webinar dedicated to primary prevention of stroke in atrial fibrillation.

• Simultaneous interpretation for Republic scientific international conference “Modern diagnostics and treatment technologies in cardiology: focus on atrial fibrillation”
  Date: April 30, 2014
  Location: Belarus, Grodno, Grodno State Medical University
  Duration: 5 hours
  Languages: English, Russian
  Field: Cardiology
  Number of participants: 100
  Simultaneous interpretation from English to Russian at the medical conference dedicated to diagnosis and treatment of atrial fibrillation.

• Simultaneous interpretation for Republic scientific international conference “Prophylaxis of stroke and myocardial infarction in patients with cardiovascular pathology”
  Date: April 24, 2014
  Location: Belarus, Vitebsk, Vitebsk State Medical University
  Duration: 5 hours
  Languages: English, Russian
  Field: Cardiology
  Number of participants: 120
  Simultaneous interpretation from English to Russian at the medical conference dedicated to prophylaxis of stroke and myocardial infarction.